Abstract
In the 12th Banff meeting held in Brazil from August 19 to 23, 2013, data from multiple clinicopathological studies as well as molecular pathology concerning pathogenesis of antibody mediated rejection (ABMR) were presented, and the revised criteria for ABMR was rigorously discussed. Other advances include the proposed refinement of criteria for C4d positivity; transplant glomerulopathy (TG), in which the cg0 score was defined as no feature of TG in the ultrastructural study; and transplant glomerulitis. In this report, the overview of these topics will be presented. A summary report of ongoing Banff working groups on isolated v-lesion and polyoma virus nephropathy is presented. The future scope of newly set working groups covering T-cell mediated rejection is also discussed.
